Not logged in.png)
Share.png)
SaveOBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy induced deepening and durable responses without interleukin 2 (IL2) in patients (pts) with immune checkpoint inhibitor (ICI)-resistant unresectable or metastatic melanoma
Amaria, Rodabe N.; McQuade, Jennifer L.; Davies, Michael A.; Oliva, Isabella C. Glitza; Jose, Steffy; Cressman, Erik N.; Clausell, Ashlynd L.; Bassett, Roland; Patel, Sapna; Diab, Adi; Tawbi, Hussein A.; Wong, Michael K.; Ikeguchi, Alexandra P.; Jagasia, Madan; Ramsingh, Giridharan; Prabhakar, Prakash; Duan, Raina; Hari, Parameswaran Share Save Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical TrialsLin, Chenyu; Schwarzbach, Aurelie; Sanz, Jaime; Montesinos, Pau; Stiff, Patrick; Parikha, Suhag; Brunstein, Claudio; Cutler, Corey; Lindemans, Caroline A.; Hanna, Rabi; Koh, Liang Piu; Jagasia, Madan H.; Valcarcel, David; Maziarz, Richard T.; Keating, Amy K.; Hwang, William Y. K.; Rezvani, Andrew R.; Karras, Nicole A.; Fernandes, Juliana F.; Rocha, Vanderson; Badell, Isabel; Ram, Ron; Schiller, Gary J.; Volodin, Leonid; Walters, Mark C.; Hamerschlak, Nelson; Cilloni, Daniela; Frankfurt, Olga; McGuirk, Joseph P.; Kurtzberg, Joanne; Sanz, Guillermo; Simantov, Ronit; Horwitz, Mitchell E. Share Save Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell TherapiesNikiforow, Sarah; Frigault, Matthew J.; Frey, Noelle, V; Gardner, Rebecca A.; Komanduri, Krishna, V; Perales, Miguel -Angel; Kebriaei, Partow; Warkentin, Phyllis Irene; Pasquini, Marcelo; Aho, Joy Lynn; Levine, Bruce L.; Heslop, Helen E.; Hlucky, Tracey L.; Habucky, Karen; Gharibo, Mecide; Jagasia, Madan; Locke, Frederick L. Share Save A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLCChesney, J.; Wise-Draper, T.; Sarnaik, A. A.; Finckenstein, F. Graf; Hari, P.; Jagasia, M.; Desai, A.; Suzuki, A.; Wu, X.; Warner, A. Betof Share Save Share Save Share Save National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group ReportPidala, Joseph; Kitko, Carrie; Lee, Stephanie J.; Carpenter, Paul; Cuvelier, Geoffrey D. E.; Holtan, Shernan; Flowers, Mary E.; Cutler, Corey; Jagasia, Madan; Gooley, Ted; Palmer, Joycelynne; Randolph, Tim; Levine, John E.; Ayuk, Francis; Dignan, Fiona; Schoemans, Helene; Tkaczyk, Eric; Farhadfar, Nosha; Lawitschka, Anita; Schultz, Kirk R.; Martin, Paul J.; Sarantopoulos, Stefanie; Inamoto, Yoshihiro; Socie, Gerard; Wolff, Daniel; Blazar, Bruce; Greinix, Hildegard; Paczesny, Sophie; Pavletic, Steven; Hill, Geoffrey Share Save Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell MalignanciesTomaszewska, Agnieszka; Jagasia, Madan; Beohou, Eric; van der Werf, Steffie; Blaise, Didier; Kanfer, Edward; Milpied, Noel; Remenyi, Peter; Ciceri, Fabio; Bourhis, Jean H.; Chevallier, Patrice; Solano, Carlos; Socie, Gerard; Bruno, Benedetto; Rambaldi, Alessandro; Castagna, Luca; Kroger, Nicolaus; Corradini, Paolo; Afanasyev, Boris; Ladetto, Marco; Niederwieser, Dietger; Scheid, Christof; Sengeloev, Henrik; Kroschinsky, Frank; Yakoub-Agha, Ibrahim; Schoemans, Helene; Koenecke, Christian; Penack, Olaf; Peric, Zinaida; Greinix, Hildegard; Duarte, Rafael F.; Basak, Grzegorz W. Share Save Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseElgarten, Caitlin W.; Li, Yimei; Getz, Kelly D.; Hemmer, Michael; Huang, Yuan-Shung, V; Hall, Matthew; Wang, Tao; Kitko, Carrie L.; Jagasia, Madan H.; Nishihori, Taiga; Murthy, Hemant S.; Hashem, Hasan; Cairo, Mitchell S.; Sharma, Akshay; Hashmi, Shahrukh K.; Askar, Medhat; Beitinjaneh, Amer; Kelly, Matthew S.; Auletta, Jeffery J.; Badawy, Sherif M.; Mavers, Melissa; Aplenc, Richard; MacMillan, Margaret L.; Spellman, Stephen R.; Arora, Mukta; Fisher, Brian T. Share Save The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemiaByrne, Michael; Danielson, Nathalie; Sengsayadeth, Salyka; Rasche, Adrianne; Culos, Katie; Gatwood, Katie; Wyatt, Houston; Chinratanalab, Wichai; Dholaria, Bhagirathbhai; Ferrell, P. Brent; Fogo, Kristin; Goodman, Stacey; Jagasia, Madan; Jayani, Reena; Kassim, Adetola; Mohan, Sanjay R.; Savani, Bipin N.; Strickland, Stephen A.; Engelhardt, Brian G.; Savona, Michael Share Save A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host diseaseSchroeder, Mark A.; Khoury, H. Jean; Jagasia, Madan; Ali, Haris; Schiller, Gary J.; Staser, Karl; Choi, Jaebok; Gehrs, Leah; Arbushites, Michael C.; Yan, Ying; Langmuir, Peter; Srinivas, Nithya; Pratta, Michael; Perales, Miguel-Angel; Chen, Yi-Bin; Meyers, Gabrielle; DiPersio, John F. Share Save Share Save Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fasciaInamoto, Yoshihiro; Lee, Stephanie J.; Onstad, Lynn E.; Flowers, Mary E. D.; Hamilton, Betty K.; Jagasia, Madan H.; Martin, Paul J.; Pavletic, Steven Z.; Pidala, Joseph A.; Pusic, Iskra; Vogelsang, Georgia B.; Wolff, Daniel; Carpenter, Paul A. Share Save Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHDJagasia, Madan; Scheid, Christof; Socie, Gerard; Ayuk, Francis Ayuketang; Tischer, Johanna; Donato, Michele L.; Batai, Arpad; Chen, Heidi; Chen, Sheau-Chiann; Chin, Thomas; Boodee, Henri; Mitri, Ghaith; Greinix, Hildegard T. Share Save Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplantsSchulthess, Duane; Gassull, Daniel; Makady, Amr; Ludlow, Anna; Rothman, Brian; ten Have, Pieter; Wu, Yiyang; Ekstrom, Leeland; Minnema, Monique; Jagasia, Madan Share Save Share Save Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center ExperienceSheth, Vipul; Kennedy, Vanessa; de lavallade, Hugues; Mclornan, Donal; Potter, Victoria; Engelhardt, Brian G.; Savani, Bipin; Chinratanalab, Wichai; Goodman, Stacey; Greer, John; Kassim, Adetola; York, Sally; Kenyon, Michelle; Gandhi, Shreyans; Kulasekararaj, Austin; Marsh, Judith; Mufti, Ghulam; Pagliuca, Antonio; Jagasia, Madan; Raj, Kavita Share Save Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory TherapyCornell, Robert Frank; Goldhaber, Samuel Z.; Engelhardt, Brian G.; Moslehi, Javid; Jagasia, Madan; Patton, Daryl; Harrell, Shelton; Hall, Robert; Wyatt, Houston; Piazza, Greg Share Save Machine learning reveals chronic graft-versus-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignanciesGandelman, Jocelyn S.; Byrne, Michael T.; Mistry, Akshitkumar M.; Polikowsky, Hannah G.; Diggins, Kirsten E.; Chen, Heidi; Lee, Stephanie J.; Arora, Mukta; Cutler, Corey; Flowers, Mary; Pidala, Joseph; Irish, Jonathan M.; Jagasia, Madan H. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
